Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401)

Authors:

Abstract
No abstract available

This publication has 21 references indexed in Scilit: